
|Videos|November 15, 2022
Interview with Simon Tasker, CEO
Author(s)Colorcon
- Colorcon capabilities – leveraging assets
- Global reach – sales, technical and manufacturing
- Innovation to solve industry challenge
Trending on Pharmaceutical Technology
1
What Does Moderna's mRNA Flu Vaccine Approval Signal?
2
How to Maintain a Productive Sponsor-CMO Relationship
3
Why the Orzeyful Approval Matters Beyond One Drug Class
4
What the OSTP’s New Policy Blueprint Means for Pharma Manufacturing and Development
5




